Skip to main content
Log in

Imaging biomarkers and radiomics in pediatric oncology: a view from the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project

  • ESPR Belgrade 2023 - Postgraduate Course and Taskforce Lectures
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

This review paper presents the practical development of imaging biomarkers in the scope of the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project, as a noninvasive and reliable way to improve the diagnosis and prognosis in pediatric oncology. The PRIMAGE project is a European multi-center research initiative that focuses on developing medical imaging-derived artificial intelligence (AI) solutions designed to enhance overall management and decision-making for two types of pediatric cancer: neuroblastoma and diffuse intrinsic pontine glioma. To allow this, the PRIMAGE project has created an open-cloud platform that combines imaging, clinical, and molecular data together with AI models developed from this data, creating a comprehensive decision support environment for clinicians managing patients with these two cancers. In order to achieve this, a standardized data processing and analysis workflow was implemented to generate robust and reliable predictions for different clinical endpoints. Magnetic resonance (MR) image harmonization and registration was performed as part of the workflow. Subsequently, an automated tool for the detection and segmentation of tumors was trained and internally validated. The Dice similarity coefficient obtained for the independent validation dataset was 0.997, indicating compatibility with the manual segmentation variability. Following this, radiomics and deep features were extracted and correlated with clinical endpoints. Finally, reproducible and relevant imaging quantitative features were integrated with clinical and molecular data to enrich both the predictive models and a set of visual analytics tools, making the PRIMAGE platform a complete clinical decision aid system. In order to ensure the advancement of research in this field and to foster engagement with the wider research community, the PRIMAGE data repository and platform are currently being integrated into the European Federation for Cancer Images (EUCAIM), which is the largest European cancer imaging research infrastructure created to date.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from PRIMAGE project but restrictions apply to the availability of these data. Data is however available from the authors upon reasonable request and with permission of PRIMAGE project.

References

  1. Martí Bonmatí L, Alberich-bayarri A, García-Martí G et al (2012) Imaging biomarkers, quantitative imaging, and bioengineering. Radiol Engl Ed 54:269–278

    Google Scholar 

  2. European Society of Radiology (ESR) (2010) White paper on imaging biomarkers. Insights Imaging 1:42–5

  3. European Society of Radiology (ESR) (2019) What the radiologist should know about artificial intelligence – an ESR white paper. Insights Imaging 10:44

  4. Voss SD (2011) Pediatric oncology and the future of oncological imaging. Pediatr Radiol 41:172–185

    Article  Google Scholar 

  5. Martí-Bonmatí L, Alberich-Bayarri Á, Ladenstein R et al (2020) PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers. Eur Radiol Exp 4:22

    Article  PubMed  PubMed Central  Google Scholar 

  6. Peschmann AL, Beer M, Ammann B et al (2019) Quantitative DWI predicts event-free survival in children with neuroblastic tumours: preliminary findings from a retrospective cohort study. Eur Radiol Exp 3:6

    Article  PubMed  PubMed Central  Google Scholar 

  7. Martí Bonmatí L, Alberich BA (2018) Imaging biomarkers: development and clinical integration. Springer, Heidelberg

    Google Scholar 

  8. Bernsen MR, Kooiman K, Segbers M et al (2015) Biomarkers in preclinical cancer imaging. Eur J Nucl Med Mol Imaging 42:579–96

  9. Papanikolaou N, Matos C, Koh DM (2020) How to develop a meaningful radiomic signature for clinical use in oncologic patients. Cancer Imaging 20:33

  10. Cui C, Chou S-HS, Brattain L et al (2019) Data engineering for machine learning in women’s imaging and beyond. Am J Roentgenol 213:216–226

  11. Daldrup-Link H (2019) Artificial intelligence applications for pediatric oncology imaging. Pediatr Radiol 49:1384–1390

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ebner H, Hayn D, Falgenhauer M et al (2016) Piloting the European Unified Patient Identity Management (EUPID) concept to facilitate secondary use of neuroblastoma data from clinical trials and biobanking. Stud Health Technol Inf 31:223

  13. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL (2022) From the archives of the AFIP: neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 22:911–934

    Article  Google Scholar 

  14. Cohn SL, Pearson ADJ, London WB et al (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report. J Clin Oncol 27:289–297

    Article  PubMed  PubMed Central  Google Scholar 

  15. Brisse HJ, Blanc T, Schleiermacher G et al (2017) Radiogenomics of neuroblastomas: relationships between imaging phenotypes, tumor genomic profile and survival. PLoS ONE 12:e0185190

  16. Morgenstern DA, Pötschger U, Moreno L et al (2018) Risk stratification of high-risk metastatic neuroblastoma: a report from the HR-NBL-1/SIOPEN study. Pediatr Blood Cancer 65:e27363

    Article  PubMed  Google Scholar 

  17. Monclair T, Brodeur GM, Ambros PF et al (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 27:298–303

  18. Chartrand G, Cheng PM, Vorontsov E et al (2017) Deep learning: a primer for radiologists. Radiographics 37:2113–2131

    Article  PubMed  Google Scholar 

  19. Cerdá Alberich L, Sangüesa Nebot C, Alberich-Bayarri A et al (2020) A confidence habitats methodology in MR quantitative diffusion for the classification of neuroblastic tumors. Cancers 12:3858

    Article  PubMed  PubMed Central  Google Scholar 

  20. Damián Segrelles Quilis J, López-Huguet S, Lozano P, Blanquer I (2023) A federated cloud architecture for processing of cancer images on a distributed storage. Future Gener Comput Syst 139:38–52

    Article  Google Scholar 

  21. Kondylakis H, Kalokyri V, Sfakianakis S et al (2023) Data infrastructures for AI in medical imaging: a report on the experiences of five EU projects. Eur Radiol Exp 7:20

    Article  PubMed  PubMed Central  Google Scholar 

  22. Fernández Patón M, Cerdá Alberich L, Sangüesa Nebot C et al (2021) MR denoising increases radiomic biomarker precision and reproducibility in oncologic imaging. J Digit Imaging 34:1134–1145

    Article  PubMed  PubMed Central  Google Scholar 

  23. Hadjiiski L, Cha K, Chan H et al (2023) AAPM task group report 273: Recommendations on best practices for AI and machine learning for computer-aided diagnosis in medical imaging. Med Phys 50:e1–e24

    Article  PubMed  Google Scholar 

  24. Gassenmaier S, Tsiflikas I, Fuchs J et al (2020) Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors. Cancer Imaging 20:89

    Article  PubMed  PubMed Central  Google Scholar 

  25. Veiga-Canuto D, Cerdà-Alberich L, Sangüesa Nebot C et al (2022) Comparative multicentric evaluation of inter-observer variability in manual and automatic segmentation of neuroblastic tumors in magnetic resonance images. Cancers 14:3648

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yasaka K, Akai H, Abe O, Kiryu S (2018) Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study. Radiology 286:887–896

    Article  PubMed  Google Scholar 

  27. Isensee F, Jaeger PF, Kohl SAA et al (2021) nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods f18:203–11

  28. deSouza NM, van der Lugt A, Deroose CM et al (2022) Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC. Insights Imaging 13:159

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ramspek CL, Jager KJ, Dekker FW et al (2021) External validation of prognostic models: what, why, how, when and where? Clin Kidney J 14:49–58

  30. Kim DW, Jang HY, Kim KW et al (2019) Design characteristics of studies reporting the performance of artificial intelligence algorithms for diagnostic analysis of medical images: results from recently published papers. Korean J Radiol 20:405

  31. Veiga-Canuto D, Cerdà-Alberich L, Jiménez-Pastor A et al (2023) Independent validation of a deep learning nnU-Net tool for neuroblastoma detection and segmentation in MR images. Cancers 15(5):1622

    Article  PubMed  PubMed Central  Google Scholar 

  32. Meeus EM, Zarinabad N, Manias KA et al (2018) Diffusion-weighted MRI and intravoxel incoherent motion model for diagnosis of pediatric solid abdominal tumors: Diagnosis of Pediatric Abdominal Tumors. J Magn Reson Imaging 47:1475–1486

    Article  PubMed  Google Scholar 

  33. Baliyan V, Das CJ, Sharma R, Gupta AK (2016) Diffusion weighted imaging: technique and applications. World J Radiol 8:785

    Article  PubMed  PubMed Central  Google Scholar 

  34. Guo J, Reddick WE, Glass JO et al (2012) Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma: DCE-MRI Prognostic in Osteosarcoma. Cancer 118:3776–3785

    Article  PubMed  Google Scholar 

  35. Lundberg SM, Lee SI (2017) A unified approach to interpreting model predictions. Adv Neural Inf Process Syst 30:4765–4774

    Google Scholar 

  36. Doi K (2007) Computer-aided diagnosis in medical imaging: historical review, current status and future potential. Comput Med Imaging Graph 31:198–211

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

PRIMAGE project consortium collaborators: Ulrike Pötschger, PhD, Sabine Taschner-Mandl, PhD, Emanuele Neri, MD, Adela Cañete, MD, PhD, Ruth Ladenstein, MD, PhD, Barbara Hero, MD, Ángel Alberich Bayarri, PhD.

Funding

This project has received funding from the European Union’s horizon 2020 research and innovation program under grant agreement No. 826494.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

L.M.B. conceived, supervised, and supported the study. D.V.C., L.C.A., M.F.P., A.J.P., and J.L.M. collated and analyzed the data and performed the formal analysis. D.V.C, L.C.A., and M.F.P. drafted the initial manuscript. A.J.P., J.L.M., A.M.B., B.M.dH, C.S.N., and L.M.B. reviewed and edited the manuscript. D.V.C. and C.S.N. segmented the images. All authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Diana Veiga-Canuto.

Ethics declarations

Ethics approval and consent to participate

This study has been approved by the Hospital’s Ethics Committee (The Ethics Committee for Investigation with medicinal products of the University and Polytechnic La Fe Hospital, ethic code: 2018/0228).

Conflicts of interest

A.J.P. and J.L.M. are employees of the company QUIBIM SL.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Veiga-Canuto, D., Cerdá Alberich, L., Fernández-Patón, M. et al. Imaging biomarkers and radiomics in pediatric oncology: a view from the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project. Pediatr Radiol 54, 562–570 (2024). https://doi.org/10.1007/s00247-023-05770-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-023-05770-y

Keywords

Navigation